Fine Mark National Bank & Trust Merck & Co., Inc. Transaction History

Fine Mark National Bank & Trust

  • $2.84 Billion
  • Q3 2024

A detailed history of Fine Mark National Bank & Trust transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 130,787 shares of MRK stock, worth $12.6 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
130,787
Previous 131,952 0.88%
Holding current value
$12.6 Million
Previous $16.3 Million 9.08%
% of portfolio
0.52%
Previous 0.6%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$111.15 - $128.97 $129,489 - $150,250
-1,165 Reduced 0.88%
130,787 $14.9 Million
Q2 2024

Aug 02, 2024
SELL
$123.8 - $132.96 $133,208 - $143,064
-1,076 Reduced 0.81%
131,952 $16.3 Million
Q1 2024

May 14, 2024
BUY
$113.24 - $131.95 $213,797 - $249,121
1,888 Added 1.44%
133,028 $17.6 Million
Q4 2023

Feb 09, 2024
SELL
$100.18 - $109.02 $211,279 - $229,923
-2,109 Reduced 1.58%
131,140 $14.3 Million
Q3 2023

Nov 15, 2023
SELL
$102.95 - $114.33 $489,939 - $544,096
-4,759 Reduced 3.45%
133,249 $13.7 Million
Q2 2023

Aug 11, 2023
SELL
$108.61 - $118.38 $420,320 - $458,130
-3,870 Reduced 2.73%
138,008 $15.9 Million
Q1 2023

May 08, 2023
SELL
$102.94 - $114.86 $1.33 Million - $1.48 Million
-12,908 Reduced 8.34%
141,878 $15.1 Million
Q4 2022

Feb 09, 2023
SELL
$87.44 - $112.11 $661,920 - $848,672
-7,570 Reduced 4.66%
154,786 $17.2 Million
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $55,451 - $62,293
-656 Reduced 0.4%
162,356 $14 Million
Q2 2022

Aug 09, 2022
BUY
$83.49 - $94.64 $110,123 - $124,830
1,319 Added 0.82%
163,012 $14.9 Million
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $157,237 - $176,253
-2,139 Reduced 1.31%
161,693 $13.3 Million
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $341,739 - $428,073
-4,728 Reduced 2.8%
163,832 $12.6 Million
Q3 2021

Nov 12, 2021
SELL
$71.68 - $78.83 $12,615 - $13,874
-176 Reduced 0.1%
168,560 $12.7 Million
Q2 2021

Aug 13, 2021
SELL
$70.31 - $77.77 $92,317 - $102,112
-1,313 Reduced 0.77%
168,736 $13.1 Million
Q1 2021

May 12, 2021
SELL
$68.86 - $81.11 $3.62 Million - $4.26 Million
-52,556 Reduced 23.61%
170,049 $13.1 Million
Q4 2020

Feb 10, 2021
SELL
$71.77 - $79.65 $327,055 - $362,965
-4,557 Reduced 2.01%
222,605 $18.2 Million
Q3 2020

Nov 12, 2020
SELL
$73.18 - $82.95 $23,783 - $26,958
-325 Reduced 0.14%
227,162 $18.8 Million
Q2 2020

Aug 13, 2020
BUY
$70.42 - $80.13 $32,111 - $36,539
456 Added 0.2%
227,487 $17.6 Million
Q1 2020

May 06, 2020
BUY
$63.36 - $87.82 $401,322 - $556,251
6,334 Added 2.87%
227,031 $17.5 Million
Q4 2019

Feb 07, 2020
BUY
$77.58 - $87.54 $354,773 - $400,320
4,573 Added 2.12%
220,697 $20.1 Million
Q3 2019

Nov 08, 2019
BUY
$76.08 - $82.93 $432,058 - $470,959
5,679 Added 2.7%
216,124 $17.4 Million
Q2 2019

Aug 08, 2019
BUY
$69.84 - $81.59 $482,594 - $563,786
6,910 Added 3.39%
210,445 $17.6 Million
Q1 2019

May 07, 2019
SELL
$69.58 - $79.36 $48,845 - $55,710
-702 Reduced 0.34%
203,535 $16.9 Million
Q4 2018

Feb 07, 2019
BUY
$65.24 - $75.71 $346,489 - $402,095
5,311 Added 2.67%
204,237 $15.6 Million
Q3 2018

Nov 02, 2018
SELL
$57.69 - $67.84 $718,932 - $845,422
-12,462 Reduced 5.9%
198,926 $14.1 Million
Q2 2018

Aug 03, 2018
BUY
$50.83 - $59.72 $241,747 - $284,028
4,756 Added 2.3%
211,388 $12.8 Million
Q1 2018

Apr 26, 2018
SELL
$50.96 - $59.23 $611 - $710
-12 Reduced 0.01%
206,632 $11.3 Million
Q4 2017

Jan 30, 2018
SELL
$51.62 - $61.64 $476,142 - $568,567
-9,224 Reduced 4.27%
206,644 $11.6 Million
Q3 2017

Oct 30, 2017
BUY
$58.67 - $63.13 $12.7 Million - $13.6 Million
215,868
215,868 $13.8 Million

Others Institutions Holding MRK

# of Institutions
3,821
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email